Journal
JOURNAL OF ASTHMA
Volume 39, Issue 2, Pages 181-185Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1081/JAS-120002199
Keywords
bronchial asthma; bronchial hyperresponsiveness; azithromycin; macrolides; histamine
Categories
Ask authors/readers for more resources
The effect of azithromycin on bronchial hyperresponsiveness was measured in a group of 11 patients with mild asthma. Azithromycin 250 mg orally was administered intermittently to all the patients twice a week for eight weeks. The only other treatment was inhaled beta2 agonist, when required. A histamine inhalation test was performed at the beginning and at the fourth and the eighth week of the study. The mean PC20 values increased significantly over the initial value at the eighth week after the administration of azithromycin (p < 0.05) but mean values for FEV1 and FEV1 percent predicted did not differ significantly. These results suggested that eight weeks of intermittent, low-dose administration of azithromycin in patients with mild asthma might reduce the severity of bronchial hyperresponsiveness.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available